Full Name
Mei-Kim Ang
 
 
Email
gmsangmk@nus.edu.sg
 

Publications

Refined By:
Department:  DUKE-NUS OFFICE OF ACAD & CLINICAL DEVT

Results 1-6 of 6 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
12019Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).Fong, Pei Yuan; Tan, Sze Huey ; Lim, Darren Wan Teck ; Tan, Eng Huat ; Ng, Quan Sing ; Sommat, Kiattisa ; Tan, Daniel Shao Weng ; Ang, Mei Kim 
216-Jul-2021Complementary Sequential Circulating Tumor Cell (CTC) and Cell-Free Tumor DNA (ctDNA) Profiling Reveals Metastatic Heterogeneity and Genomic Changes in Lung Cancer and Breast CancerKong, Say Li; Liu, Xingliang; Tan, Swee Jin; Tai, Joyce A; Phua, Ler Yee; Poh, Huay Mei ; Yeo, Trifanny; Chua, Yong Wei; Haw, Yu Xuan; Ling, Wen Huan ; Ng, Raymond Chee Hui ; Tan, Tira J ; Loh, Kiley Wei Jen ; Tan, Daniel Shao-Weng ; Ng, Quan Sing ; Ang, Mei Kim ; Toh, Chee Keong; Lee, Yi Fang; Lim, Chwee Teck ; Lim, Tony Kiat Hon; Hillmer, Axel M; Yap, Yoon Sim ; Lim, Wan-Teck 
32015Impact of smoking and brain metastasis on outcomes of advanced EGFR mutation lung adenocarcinoma patients treated with first line epidermal growth factor receptor tyrosine kinase inhibitorsJain A.; Lim C. ; Gan E.M.; Ng D.Z.; Ng Q.S.; Ang M.K. ; Takano A. ; Chan K.S. ; Tan W.M.; Kanesvaran R. ; Toh C.K. ; Loo C.M. ; Hsu A.A.L. ; Devanand A. ; Lim C.H. ; Koong H.N. ; Koh T. ; Fong K.W. ; Yap S.P.; Kim S.W.; Chowbay B. ; Oon L. ; Lim K.H. ; Lim W.T. ; Tan E.H. ; Tan D.S.W. 
43-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastasesTan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
524-Dec-2018Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases (vol 18, 1198, 2018)Tan, Wan-Ling ; Ng, Quan Sing ; Lim, Cindy; Tan, Eng Huat ; Toh, Chee Keong; Ang, Mei-Kim ; Kanesvaran, Ravindran ; Jain, Amit ; Tan, Daniel SW ; Lim, Darren Wan-Teck 
62016Phase I study of oral vinorelbine in combination with erlotinib in advanced non-small cell lung cancer (NSCLC) using two different schedulesSutiman N.; Zhang Z.; Ang M.K. ; Tan S.-W.D.; Toh C.K.; Ng Q.S.; Chowbay B. ; Lim W.-T.